Dr. Gabriel Sosne
Biography & Research Background
Gabriel Sosne, M.D., is affiliated with Wayne State University (Kresge Eye Institute). Dr. Sosne has extensively studied the ophthalmic applications of Thymosin Beta-4 and its fragments. He co-authored research defining the biological activities of short peptide sequences — including the 17–23 fragment (TB-500) — involved in cell migration, wound healing, and anti-apoptosis. His work has been critical in translating these findings into clinical trials for corneal repair and dry eye (RGN-259). Gabriel Sosne is being referenced as one of the leading scientists involved in the research and development of TB-500 and Thymosin Beta-4. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Gabriel Sosne is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Gabriel Sosne is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.